FindTrial
Sign In

association of cardiac markers with severity of covid 19

Correlation between myocardial enzyme serum levels and markers of inflammation with severity of COVID 19:A prospective observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027001
Enrollment
70
Registered
2020-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: cardiac biomarkers: cardiac biomarkers will be considered in all patients admitted to covid center Control Intervention2: Nil: Nil

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all Male and female patient will be taken for study.

Exclusion criteria

Exclusion criteria: known case of myocardial infarction

Design outcomes

Primary

MeasureTime frame
correlation between covid 19 severity andTimepoint: 24 weeks—

Secondary

MeasureTime frame
association between cardiac markers and covid severityTimepoint: 24 weeks—

Countries

India

Contacts

Public ContactSunder Lal Negi

deptt of anaesthesia

dr.sundernegi@gmail.com7087009506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026